Description:
Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
- Molecular Weight: 472.553
- Molecular Formula: C25H28N8O2
Purity: 0.99
Canonical SMILES:
CC4=NC5=CC=CC=C5C(=N4)C)C
InChI:
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
InChIKey: LTXREWYXXSTFRX-QGZVFWFLSA-N
- Melting Point: 190-196°C
- Appearance: Off-White to Yellowish Orange Solid
- Application: the treatment of type 2 diabetes
Synonyms:
Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta
More details are to be found on supplier website
